Tetraphase Pharmaceuticals, Inc. Gains 78.6%
Thu 07 May 20 at 05:30 PM
Tetraphase Pharmaceuticals, Inc. (TTPH:NASDAQ) rocketted at $2.42, representing a gain of 78.6%. On Wed 06 May 20, TTPH:NASDAQ touched a New 2-Week Intraday High of $1.55. The stock appeared on our News Catalysts scanner on Thu 30 Apr 20 at 06:19 PM in the 'INVESTOR UPDATE' category. From Wed 22 Apr 20, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Fri 27 Dec 19 at $4.3 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Tetraphase Pharmaceuticals, Inc. (TTPH:NASDAQ)
Tetraphase Pharmaceuticals Inc is a clinical stage biopharmaceutical company engaged in creating novel antibiotics for serious and life-threatening multidrug-resistant infections.
Top 10 Gainers:
- WISeKey International Holding AG (WKEY:NASDAQ), 137.5%
- Tetraphase Pharmaceuticals, Inc. (TTPH:NASDAQ), 78.6%
- Genius Brands International, Inc. (GNUS:NASDAQ), 73.9%
- ION Geophysical Corporation (IO:NYSE), 58.08%
- Fastly, Inc. (FSLY:NYSE), 45.68%
- Waitr Holdings Inc. (WTRH:NASDAQ), 44.44%
- Twilio Inc. (TWLO:NYSE), 39.62%
- Therapix Biosciences Ltd. (TRPX:NASDAQ), 39.09%
- Mogo Inc. (MOGO:NASDAQ), 36.24%
- Huitao Technology Co., Ltd. (HHT:NASDAQ), 35.59%